The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?

BACKGROUND: In the last decade, the combination of the widespread use of streptavidin–biotin technology and biotin–containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous hormone immunoassay results. However, there are no studies assessing the clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Angelopoulos, Nicholas, Paparodis, Rodis D., Androulakis, Ioannis, Anagnostis, Panagiotis, Boniakos, Anastasios, Duntas, Leonidas, Karras, Spyridon N., Livadas, Sarantis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351174/
https://www.ncbi.nlm.nih.gov/pubmed/37455308
http://dx.doi.org/10.1186/s13044-023-00162-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351174/
https://www.ncbi.nlm.nih.gov/pubmed/37455308
http://dx.doi.org/10.1186/s13044-023-00162-8

Ejemplares similares